个人科研网厅 | | 帮助
高级检索
当前位置： 首页 > 详情页

Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study.

| 认领 | 导出 | |

文献详情

资源类型：
Pubmed体系：

收录情况： ◇ 预警期刊

作者：
Wang Zizhuo[1,2] * ; Song Kun[3] * ; Liu Jingbo[1,2] * ; Zhang Qing[3] * ; Zhang Chuyao[4] ; Wang Beibei[1,2] ; Fu Yu[1,2] ; Wang Yu[5] ; Yao Shuzhong[6] ; Xu Congjian[7] ; Xia Min[8] ; Lou Ge[9] ; Liu Jihong[4] ; Lin Bei[10] ; Wang Jianliu[11] ; Zhao Weidong[12] ; Zhang Jieqing[13] ; Cheng Wenjun[14] ; Guo Hongyan[15] ; Guo Ruixia[16] ; Xue Fengxia[17] ; Wang Xipeng[18] ; Han Lili[19] ; Zhao Xia[20] ; Li Xiaomao[21] ; Zhang Ping[22] ; Zhao Jianguo[23,24,25] ; Ma Jiezhi[26] ; Yao Qin[27] ; Li Wenting[1,2] ; Yang Xiaohang[1,2] ; Fang Yong[1,2] ; Chen Gang[1,2] ; Li Kezhen[1,2] ; Shen Yuanming[5] ; Sun Chaoyang[1,2] ; Kong Beihua[3] ;
单位： [1]Key Laboratory of the Ministry of Education, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [2]Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [3]Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan, China. [4]Department of Gynecologic Oncology, Sun Yat-sen University Cancer Center, Guangzhou, China. [5]Women's Hospital, School of Medicine, Zhejiang University, Hangzhou, China. [6]Department of Obstetrics and Gynecology, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. [7]Department of Gynecology, Obstetrics and Gynecology Hospital of Fudan University, Shanghai, China. [8]Department of Obstetrics and Gynecology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai, China. [9]Department of Gynecology Oncology, Harbin Medical University Cancer Hospital, Harbin, China. [10]Department of Obstetrics and Gynecology, ShengJing Hospital of China Medical University, Shenyang, China. [11]Peking University People's Hospital, Beijing, China. [12]Division of Life Sciences and Medicine, The First Affiliated Hospital of USTC, University of Science and Technology of China, Hefei, China. [13]Department of Gynecologic Oncology, Guangxi Medical University Cancer Hospital, Nanning, China. [14]The First Affiliated Hospital of Nanjing Medical University, Nanjing, China. [15]Peking University Third Hospital, Beijing, China. [16]Department of Obstetrics and Gynecology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China. [17]Department of Obstetrics and Gynecology, Tianjin Medical University General Hospital, Tianjin, China. [18]Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. [19]Department of Gynecology, People's Hospital of Xinjiang Uygur Autonomous Region, Ürümqi, China. [20]Development and Related Disease of Women and Children Key Laboratory of Sichuan Province, Key Laboratory of Birth Defects and Related Diseases of Women and Children, Ministry of Education, Department of Gynecology and Obstetrics, West China Second Hospital, Sichuan University, Chengdu, China. [21]Department of Obstetrics and Gynecology, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, China. [22]Department of Gynecology, The Second Hospital of Shandong University, Jinan, China. [23]Department of Gynecologic Oncology, Tianjin Central Hospital of Gynecology and Obstetrics, Affiliated Hospital of Nankai University, Tianjin, China. [24]Tianjin Clinical Research Center for Gynecology and Obstetrics, Tianjin, China. [25]Branch of National Clinical Research Center for Gynecology and Obstetrics, Tianjin, China. [26]Department of Obstetrics and Gynecology, The Third Xiangya Hospital, Central South University, Changsha, China. [27]Department of Obstetrics and Gynecology, The Affiliated Hospital of Qingdao University, Qingdao, China.
出处：
DOI： 10.3389/fmed.2022.830673
ISSN：

摘要：
Patients with endometrial cancer (EC) combined with metabolic syndrome (MetS) have a worse prognosis than those without MetS. This study aimed to investigate whether partial metabolic disorder significantly influenced early-stage endometrioid EC (EEC) survival and searched for a more efficient method to evaluate metabolic status.This is a nationwide, multicenter cohort study that included 998 patients with primary early-stage EEC from 2001 to 2018. Patients were divided into different metabolic groups based on the diagnostic criteria of the Chinese Medical Association (CDC). The progression-free survival (PFS) time was compared between various metabolic status. Meanwhile, we established an EC Prognostic-Related Metabolic Score (ECPRM Score) to explore the association of the severity of metabolic status and early-stage EEC PFS. A nomogram was established for predicting PFS, which was externally validated in a testing set that includes 296 patients.A partial metabolic disorder, as well as MetS, was an independent risk factor of poor survival of patients with early-stage EEC [hazard ratio (HR) = 7.6, 95% CI = 1.01-57.5, p < 0.05]. A high ECPRM Score was associated with lower PFS (HR = 2.1, 95% CI = 1.05-4.0, p < 0.001). The nomogram, in which the ECPRM Score contributed most to the prognosis, exhibited excellent discrimination of survival supported by the internal and external validations. In addition, the calibration curve supports its robust predicting ability.Even though they do not meet the criteria of MetS, partial metabolic disorders were also associated with adverse outcomes in early-stage EEC. The ECPRM Score is beneficial for clinicians to evaluate the severity of metabolic abnormalities and guide patients to ameliorate the poor prognosis of metabolic disorders.Copyright © 2022 Wang, Song, Liu, Zhang, Zhang, Wang, Fu, Wang, Yao, Xu, Xia, Lou, Liu, Lin, Wang, Zhao, Zhang, Cheng, Guo, Guo, Xue, Wang, Han, Zhao, Li, Zhang, Zhao, Ma, Yao, Li, Yang, Fang, Chen, Li, Shen, Sun and Kong.

基金：
the National Key Technology R&D Program of China (Grant Numbers 2019YFC1005200 and 2019YFC1005204), the National Natural Science Foundation of China (Grant Number U18o6202), the Taishan Scholar Youth Project of Shandong Province (Grant Number tsqn201812130), and the Research Leader Studio of Jinan (Grant Number 2019GXRC049), the Nature and Science Foundation of China (Grant Numbers 81874106, 82073259, and 81974408), the Key R&D Program of Hubei Province (Grant Number 2020BCA067), and the Hubei Province Science Fund for Distinguished Young Scholars (Grant Number 2020CFA066).
语种：
外文
PubmedID：
中科院(CAS)分区：
出版当年[2021]版：
大类 | 3 区 医学
小类 | 2 区 医学：内科
最新[2025]版：
大类 | 3 区 医学
小类 | 3 区 医学：内科
第一作者：
第一作者单位： [1]Key Laboratory of the Ministry of Education, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [2]Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
共同第一作者：
通讯作者：
通讯机构： [1]Key Laboratory of the Ministry of Education, Cancer Biology Research Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China. [2]Department of Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.
推荐引用方式(GB/T 7714)：
Wang Zizhuo,Song Kun,Liu Jingbo,et al.Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study.[J].Frontiers in medicine.2022,9:830673.doi:10.3389/fmed.2022.830673.
APA：
Wang Zizhuo,Song Kun,Liu Jingbo,Zhang Qing,Zhang Chuyao...&Kong Beihua.(2022).Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study..Frontiers in medicine,9,
MLA：
Wang Zizhuo,et al."Prognostic-Related Metabolic Score for Survival Prediction in Early-Stage Endometrioid Endometrial Cancer: A Multi-Center and Retrospective Study.".Frontiers in medicine 9.(2022):830673

资源点击量：589 今日访问量：0 总访问量：441 更新日期：2025-06-01 建议使用谷歌、火狐浏览器 常见问题

版权所有：重庆聚合科技有限公司 渝ICP备12007440号-3 地址：重庆市两江新区泰山大道西段8号坤恩国际商务中心16层（401121）